Summary We have isolated from Chinese hamster ovary cells, 30 sublines resistant to vincristine, doxorubicin or etoposide and 43 sublines evading treatment with a pair of these drugs. Isolated in one step and under low selective pressure. subhnes were 3-to 25-fold more resistant to their selecting drug(s) than the parental cells. Possible P-glycoprotein-associated multidrug resistance was investigated through pgp gene copy number and mRNA expression level. DNA topoisomerase II alteration was evaluated from the ability of nuclear extracts to form cleavable complexes. Vincristine (all sublines) and doxorubicin (6 7 sublines) preferentially selected for pgp gene amplification and mRNA overexpression, whereas selection with etoposide resulted in a decrease of cleavable complex formation in 11 out of 13 sublines. A common pgp gene-mediated resistance was found in the 13 doxorubicin plus vincristine-selected sublines, whereas all but one of the 12 etoposide plus vincristineresistant sublines displayed both pgp mRNA overexpression and decreased ability to form cleavable complexes. Among the 18 doxorubicin plus etoposide selected sublines, five exhibited a decreased ability to form cleavable complexes only, six exhibited pgp mRNA overexpression only and six exhibited both alterations. Overall, drug resistance could not be attributed to either mechanism in three of the 73 sublines. We conclude that under low selective pressure it is possible to find a combination of drugs which require simultaneous selection of more than one resistance mechanism; such cells emerge with very low frequency.
Drug resistance is, beside the poor selectivity of antitumoral agents, the main limitation of cancer chemotherapy (Goldie and Coldman, 1984) . Regimens usually involve at least two drugs, but resistance often develops simultaneously to several agents. Typically, the frequency of resistance to combined drugs is much higher than the product of the monoresistant frequencies (Giulotto et al., 1987; Rice et al., 1987; Soues and Charcosset, 1993) . Multiple immunities may result from a specific phenotype, characterised by DNA amplification. For instance, the high frequency of simultaneous resistance to methotrexate and N-phosphonacetyl-L-aspartate is due to gene amplification of both target enzymes: dihydrofolatereductase and polypeptide having carbamyl phosphate synthetase, aspartate transcarbamylase and dihydroorotase activities (CAD) (Giulotto et al., 1987) . Similarly, concurrent treatment with methotrexate and doxorubicin (DOX) induces amplification of the dihydrofolate reductase and of the multidrug resistance-associated genes (Rice et al., 1987) . Multiple drug resistance (MDR) may also follow overexpression of the multidrug efflux pump P-glycoproteins (PGP), coded by three classes of genes (Georges et al., 1990; Gottesman and Pastan, 1993) . Transfection of hamster pgpl (class I genes) and of mouse mdrl gene, homologous to the hamster pgp2 gene (class II genes), has been shown to induce the classical MDR phenotype (Gottesman and Pastan, 1993; Devine and Melera, 1994) . Modification of DNA topoisomerase II, or a nuclear decrease in this enzyme, may also confer resistance to several of its poisons (Charcosset et al., 1988; Fernandes et al., 1990; Schneider et al., 1990; Harker et al., 1991; Hinds et al., 1991; Rappa et al., 1992) , the phenotype being referred to as atypical MDR (at MDR) (Danks et al., 1988) .
Etoposide (ETO) is an epipodophyllotoxin derivative which selects cells with quantitative and/or qualitative alterations of DNA topoisomerase II (Ferguson et al., 1988; Long et al., 1991; Takano et al., 1991; Webb et al., 1991; Danks et al., 1993; Patel and Fisher, 1993; Sullivan et al., 1993; Ritke et al., 1994) . To date, only one cell line exhibited mdrl mRNA overexpression, without topoisomerase II modification, after selection by teniposide (Long et al., 1991) . Vincristine (VCR) is a vinca alkaloid which selects for modified tubulin, its target (Houghton et al., 1985; Pain et al., 1988) , or for PGP overexpression (Georges et al., 1990) . Finally, DOX is a DNA intercalative drug, which selects for DNA topoisomerase II modification (De Jong et al., 1990; McPherson et al., 1993) as well as for the MDR phenotype (Georges et al., 1990; Slapak et al., 1990) .
In previous studies, we reported that the frequencies of resistance to combinations of DOX, VCR and ETO suggest that both common and independent mechanisms of resistance can be selected in Chinese hamster ovary (CHO) cells (Soues and Charcosset, 1993) . In this paper, we document that VCR and DOX preferentially select CHO cells with amplification and overexpression of the pgp genes, whereas DNA topoisomerase II alteration almost systematically accounts for ETO resistance. We also provide evidence that amplification of the pgp genes develops without DNA topoisomerase II modification after treatment with VCR plus DOX, whereas both pgp gene amplification and DNA topoisomerase II alteration occur in VCR plus ETO-selected sublines. When the selection is achieved with a combination of DOX plus ETO, drug resistance is ensured by either or both mechanisms. We conclude that cells selected with two drugs tend to exhibit a mechanism that allows them to resist both drugs simultaneously. Alternatively cells need two, independent, mechanisms of resistance.
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purchased from Laboratoire Roger Bellon (Neuilly-sur-Seine, France) and stored at -20-C after dissolution in water at 1 mg ml-'. ETO was kindly provided by Drs (Muler et al., 1992) . No inoculum effect was observed with either parental or seled cells (Ohnuma et al., 1986) . Each cell lne was characterised by the concentration of drug resulting in 10% survival (D1O) and by its resistance index (RI), defined as the ratio of the D0 value for a particular subline over that for the parental cell line.
Northern and Southern blots RNA and DNA were extracted by the guanidine thiocyanate method, separated using a caesium chloride cushion (Chirgwin et al., 1979; Muller et al., 1992) moderately overexpressed (Figure 2 Taken together, these data suggest that VCR typically selects AA8 cells with amplification and overexpression of pgp genes resulting in cross-resistance to DOX and ETO.
Characterisation of the ETO-resistant sublines A decreased ability to form cleavable complexes was observed in 11 out of the 13 ETO-resistant sublines, whereas none exhibited pgp gene amplification (Figure 3) Figure 4 Charactenrsation of the DOX plus VCR-resistant sublines. Top: resistance indexes to DOX ( _ ) and to VCR x ).
Middle: Southern blot analysis. Bottom: fold increase in pgp mRNA level (as in Figure 1 ). All sublines exhibited a homogeneous pgp gene amplification pattern, except subline B3, which presents a preferred pgp2 amplification pattern. All sublines overexpressed to vanous extents the pgp mRNA. No alteration of the ability to form cleavable complexes was detected (not shown). Figure 1 ) and ability to form cleavable complexes (as in Figure 3 ). Seven sublines exhibited a homogeneous pgp gene amplification pattern (A3, B2, B3, C3, C6, F2 and G2), the other sublines (A6, BI, B4, E3 and F3) a preferred pgp2 amplification pattern. All sublines overexpressed to various extents the pgp mRNA, and all but subline E3 had a reduced ability to form cleavable complexes. Figure 1 ) and ability to form cleavable complexes (as in Figure 3) (Singh and Gupta, 1983) . Therefore, it is likely that the selection resulted from a threshold effect:
there were pre-existing mutants which emerged from the parental population. Consistent with our observations, a low concentration of vinblastine or colchicine with human melanoma cells (Lemontt et al., 1988) , or of DOX with murine erythroleukaemia cells (Slapak et al., 1990) (Liu, 1989; Georges et al., 1990; Corbett et al., 1993; Gottesman and Pastan, 1993 (Bradley et al., 1989; Hill et al., 1990; Biedler, 1994) . Resistance to VCR could result from tubulin alteration (Houghton et al., 1985; Sirotnak et al., 1986; Pain et al., 1988) . Such a mechanism possibly accounts for two of the VCR-resastant subines exhibiting only a slight increase in pgp mRNA. Alternatively, point mutations in PGP could affect the transporter affinity for a particular drug (Gottesman and Pastan, 1993) . Fmally, specific drug immunity may be associated with a particular pgp gene (Georges et al., 1990; Gottesman and Pastan, 1993) .
Three patterns of pgp gene amplifiction were established in the CHO-AA8 cells. The most common patten was a general amplification of all three pgpl, pgp2 and pgp3 genes. A specific pgpl amplfication pattern was found in the VCRselected cells, and a preferential amplification of pgp2 gene characterised some of the DOX-selected cells. In sublines displaying a general amplfication pattern, the Rls to DOX were higher than those to VCR, and the resistance to ETO the lowest. In sublines with specific pgpl amplifiation, the highs Rls were to VCR, and a relationship seemed to link the extent of pgpl amplification to the level of VCR resistance. Similarly, a preferred pgp2 amplification may improve the resistance to DOX. We did not find a specific pgp3 gene amplification, but transfection of the human mdr3 gene (homologous to the hamster pgp3 gene) failed to induce the MDR phenotype in RBO melanoma cells (Gottesman and Pastan, 1993) . While DOX and ETO are both topoisomerase H poisons, they appear to seect preferentially different mechanisms of resistance. Topoisomerase H modifications obtained through DOX selection were far less frequent than those emerging through ETO selection. Actually, the unique DOX-selected subline exhibiting topoisomerase H alteration was only 3-fold cross-resistant to ETO. Conversely, the ETOselected sublines which exhibited an impaired ability to form cleavabk complexes were at most 2-fold cross-resistant to DOX. However, the DOX-(or VCR) resistant sublines (overexpressing the pgp genes) were cross-resistant to at., 1994; Schneider et al., 1994) , inducibl P450 dependent drugmetabolsing activity (Sinha et al., 1988) and alteration of an enzyme involved in the glutathione metabolism (Sinha and Myers, 1984; Haim et al., 1987) .
With all the DOX plus VCR-resistant sublines, there was a common mechanism of resistance, which corresponded to the one preferentiallyseted by each drug alone. Simultaneous resstance to both drugs may have resulted from overexpression of a singe PGP (which would recognise both drugs).
Alternively, concurrent amp tion of disct pgp genes, coding for different PGP, may account for the double drug resistance (Ng et al., 1989; Gottesman and Pastan, 1993 (Bradley et al., 1989; Hill et al., 1990) , other modifications, as above, may have conferred resitance to ETO (Sinha and Myers, 1984; Haim et al., 1987; Sinha et al., 1988; Schneider et al., 1994) and DOX (Sinha and Chigneli, 1979; Berlin and Haseltine, 1981; Zaman et al., 1993; Barrand et al., 1994) . Resistance to both drugs could also result from alteration in the lethal processing of the cleavable complexes (Schneider et al., 1990; Glisson et al., 1992 
